Skip to product information
1 of 1

MULTI SCIENCES

Mouse IL-1 Alpha ELISA Kit Distributor

Mouse IL-1 Alpha ELISA Kit Distributor

SKU:EK201A

Regular price Send Inquiry
Regular price Sale price Send Inquiry
Sale Sold out
View full details

Product Details

Mouse IL-1 Alpha ELISA Kit Distributor

Brand MultiSciences
CatNum 70-EK201A
Product Name Mouse IL-1α ELISA Kit
Customs Name Mouse IL-1α ELISA Kit
Application ELISA
Reactivity Mouse
Assay Type Sandwich ELISA
Suitable Sample Type serum, plasma, cell culture supernates
Format 96-well strip plate
Storage 4℃ (unopened) standard stored at -20℃, others stored at 4℃ (opened)
Shipping Condition 4℃
Sample Volume 20 μl
Sensitivity 1.68 pg/ml
Standard Curve Range 7.81 - 500 pg/ml
Spike Recovery Range 71 % - 106 %
Mean Spike Recovery 89%
CV of Intra plate 4.7 % - 7.7 %
CV of Inter plate 4.3 % - 6.3 %
Components 96-well polystyrene microplate coated with a monoclonal antibody against Mouse IL-1α
Mouse IL-1α Standard, lyophilized
Mouse IL-1α Detect Antibody
Standard Diluent
Streptavidin-HRP
Assay Buffer (10×)
Substrate (TMB)
Stop Solution
washing Buffer (20×)
Plate Covers
Describtion This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of mouse IL-1α. The Mouse IL-1α ELISA is for research use only. Not for diagnostic or therapeutic procedures.
Interleukin-1 (IL-1) is an extracellular peptide of 17 kDa that designates two proteins, IL-1α and IL-1β. IL-1α is a pleiotropic cytokine that in humans is encoded by the IL1A gene. IL-1α is produced mainly by activated macrophages, as well as neutrophils, epithelial cells, and endothelial cells. It possesses metabolic, physiological, haematopoietic activities, and plays one of the central roles in the regulation of the immune responses.
IL-1α has been shown to interact with HAX1 and NDN, but the most clinically relevant is its synergism with TNF. IL-1α and TNF are both acute-phase cytokines that act to promote fever and inflammation.
IL-1α is currently being evaluated in clinical trials as a potential therapeutic in oncology indications. Blocking the activity of IL-1α has the potential to treat skin diseases such as acne.